Is UBX or DIVO a better dividend investment in 2026?

UBX currently yields 999.50% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: UBX offers higher current income.

What is the dividend yield difference between UBX and DIVO?

UBX has a forward dividend yield of 999.50% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 993.01 percentage points.

Home › Compare › UBX vs DIVO

UBX vs DIVO: Dividend Comparison 2026

UBX yields 999.50% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 UBX wins by $18762502.85M in total portfolio value

INVESTMENT

TIME HORIZON10 years

UBX

● Live price

999.50%

Share price

$0.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$18762502.88M

Annual income

$15,677,048,250,727.08

Full UBX calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — UBX vs DIVO

📍 UBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	UBX	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, UBX + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

UBX pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBX

Annual income on $10K today (after 15% tax)

$84,957.52/yr

After 10yr DRIP, annual income (after tax)

$13,325,491,013,118.02/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, UBX beats the other by $13,325,491,012,283.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBX + DIVO for your $10,000?

UBX: 50%DIVO: 50%

100% DIVO50/50100% UBX

Portfolio after 10yr

$9381251.46M

Annual income

$7,838,524,125,854.38/yr

Blended yield

83.56%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on UBX right now

UBX

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$2.50

+1149.4% upside vs current

Range: $1.00 — $4.00

Altman Z

-26.4

Piotroski

2/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBX buys

DIVO buys

No recent congressional trades found for UBX or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricUBXDIVO

Forward yield	999.50% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$18762502.88M ✓	$30.7K
Annual income after 10y	$15,677,048,250,727.08 ✓	$981.68
Total dividends collected	$18526733.01M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: UBX vs DIVO ($10,000, DRIP)

Year	UBX Portfolio	UBX Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$110,650	$99,950.02	$11,349	$649.42	+$99.3K → UBX
2	$1,151,991	$1,033,595.59	$12,833	$688.83	+$1.14M → UBX
3	$11,289,539	$10,056,908.06	$14,459	$727.90	+$11.28M → UBX
4	$104,190,015	$92,110,208.43	$16,238	$766.49	+$104.17M → UBX
5	$905,946,717	$794,463,401.71	$18,179	$804.47	+$905.93M → UBX
6	$7,425,409,853	$6,456,046,865.26	$20,293	$841.71	+$7425.39M → UBX
7	$57,399,102,727	$49,453,914,184.22	$22,591	$878.14	+$57399.08M → UBX
8	$418,691,166,930	$357,274,127,011.89	$25,087	$913.65	+$418691.14M → UBX
9	$2,883,602,458,699	$2,435,602,910,084.79	$27,791	$948.18	+$2883602.43M → UBX
10	$18,762,502,881,535	$15,677,048,250,727.08	$30,718	$981.68	+$18762502.85M → UBX

UBX vs DIVO: Complete Analysis 2026

UBX — Stock

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Full UBX Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this UBX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBX vs SCHD UBX vs JEPI UBX vs O UBX vs KO UBX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.